Baolingbao Biology Co Ltd (002286) — Tangible Net Worth Ratio
Baolingbao Biology Co Ltd (002286) has a Tangible Net Worth Ratio of 95.1% as of March 2026. This metric is calculated by deducting intangible assets (CN¥113.78 Million) from net assets (CN¥2.30 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Baolingbao Biology Co Ltd annual equity growth to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Baolingbao Biology Co Ltd Tangible Net Worth Ratio (2006–2025)
This chart shows how Baolingbao Biology Co Ltd's Tangible Net Worth Ratio has changed across 20 annual periods from 2006 to 2025. As of March 2026, the ratio stands at 95.1%, reflecting net assets of CN¥2.30 Billion with intangible assets of CN¥113.78 Million CNY. For live market cap and overall valuation, see market value of Baolingbao Biology Co Ltd.
Annual Tangible Net Worth Ratio for Baolingbao Biology Co Ltd (2006–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Baolingbao Biology Co Ltd from 2006 to 2025, covering 20 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore Baolingbao Biology Co Ltd (002286) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 94.9% | CN¥2.23 Billion | CN¥114.11 Million | CN¥2.78 Billion | ▲ +0.6 pp |
| 2024 | 94.2% | CN¥2.04 Billion | CN¥117.50 Million | CN¥2.67 Billion | ▲ +0.4 pp |
| 2023 | 93.9% | CN¥1.98 Billion | CN¥121.28 Million | CN¥2.66 Billion | ▲ +0.1 pp |
| 2022 | 93.8% | CN¥2.00 Billion | CN¥125.07 Million | CN¥3.01 Billion | ▲ +0.9 pp |
| 2021 | 92.9% | CN¥1.81 Billion | CN¥129.27 Million | CN¥3.03 Billion | ▲ +1.2 pp |
| 2020 | 91.6% | CN¥1.60 Billion | CN¥133.60 Million | CN¥2.62 Billion | ▲ +0.3 pp |
| 2019 | 91.4% | CN¥1.57 Billion | CN¥134.93 Million | CN¥2.52 Billion | ▲ +0.3 pp |
| 2018 | 91.1% | CN¥1.54 Billion | CN¥137.68 Million | CN¥2.58 Billion | ▲ +0.3 pp |
| 2017 | 90.8% | CN¥1.53 Billion | CN¥140.36 Million | CN¥2.11 Billion | ▲ +0.3 pp |
| 2016 | 90.5% | CN¥1.51 Billion | CN¥143.45 Million | CN¥1.93 Billion | ▼ -0.5 pp |
| 2015 | 91.0% | CN¥1.48 Billion | CN¥133.00 Million | CN¥1.91 Billion | ▼ -1.4 pp |
| 2014 | 92.4% | CN¥1.45 Billion | CN¥110.32 Million | CN¥1.77 Billion | ▲ +0.3 pp |
| 2013 | 92.1% | CN¥1.44 Billion | CN¥113.37 Million | CN¥1.68 Billion | ▲ +6.3 pp |
| 2012 | 85.8% | CN¥817.45 Million | CN¥116.30 Million | CN¥1.11 Billion | ▲ +0.1 pp |
| 2011 | 85.7% | CN¥760.53 Million | CN¥108.72 Million | CN¥1.11 Billion | ▲ +1.3 pp |
| 2010 | 84.5% | CN¥703.11 Million | CN¥109.31 Million | CN¥1.03 Billion | ▼ -3.6 pp |
| 2009 | 88.0% | CN¥662.61 Million | CN¥79.25 Million | CN¥1.08 Billion | ▲ +13.2 pp |
| 2008 | 74.9% | CN¥238.05 Million | CN¥59.80 Million | CN¥743.91 Million | ▲ +6.5 pp |
| 2007 | 68.3% | CN¥193.28 Million | CN¥61.20 Million | CN¥601.90 Million | ▲ +20.9 pp |
| 2006 | 47.4% | CN¥112.53 Million | CN¥59.17 Million | CN¥507.93 Million | — |